KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$1.5 billion.

  • Bristol Myers Squibb's Cash from Investing Activities fell 64387.76% to -$1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.1 billion, marking a year-over-year increase of 8064.82%. This contributed to the annual value of -$4.1 billion for FY2025, which is 8064.82% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Cash from Investing Activities stood at -$1.5 billion for Q4 2025, which was down 64387.76% from -$1.7 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Cash from Investing Activities' 5-year high stood at $1.2 billion during Q4 2022, with a 5-year trough of -$19.6 billion in Q1 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Cash from Investing Activities value was -$369.5 million (recorded in 2023), while the average stood at -$1.5 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Cash from Investing Activities surged by 20249.38% in 2022, and later tumbled by 924190.48% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Cash from Investing Activities (Quarter) stood at $401.0 million in 2021, then surged by 202.49% to $1.2 billion in 2022, then plummeted by 210.96% to -$1.3 billion in 2023, then surged by 85.44% to -$196.0 million in 2024, then tumbled by 643.88% to -$1.5 billion in 2025.
  • Its Cash from Investing Activities stands at -$1.5 billion for Q4 2025, versus -$1.7 billion for Q3 2025 and -$473.0 million for Q2 2025.